These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. FGF23-FGF Receptor/Klotho Pathway as a New Drug Target for Disorders of Bone and Mineral Metabolism. Fukumoto S Calcif Tissue Int; 2016 Apr; 98(4):334-40. PubMed ID: 26126937 [TBL] [Abstract][Full Text] [Related]
7. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis. Koizumi M; Komaba H; Fukagawa M Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554 [TBL] [Abstract][Full Text] [Related]
8. [Clinical aspect of recent progress in phosphate metabolism. The pathophysiology of diseases caused by aberrant actions of FGF23]. Shimizu Y; Fukumoto S Clin Calcium; 2009 Jun; 19(6):802-7. PubMed ID: 19483274 [TBL] [Abstract][Full Text] [Related]
9. FGF receptors control vitamin D and phosphate homeostasis by mediating renal FGF-23 signaling and regulating FGF-23 expression in bone. Wöhrle S; Bonny O; Beluch N; Gaulis S; Stamm C; Scheibler M; Müller M; Kinzel B; Thuery A; Brueggen J; Hynes NE; Sellers WR; Hofmann F; Graus-Porta D J Bone Miner Res; 2011 Oct; 26(10):2486-97. PubMed ID: 21812026 [TBL] [Abstract][Full Text] [Related]
10. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Role of FGF23-Klotho axis in CKD-MBD]. Komaba H Clin Calcium; 2010 Jul; 20(7):1028-36. PubMed ID: 20585181 [TBL] [Abstract][Full Text] [Related]
11. Regulation of fibroblast growth factor 23 (FGF23) in health and disease. Bär L; Stournaras C; Lang F; Föller M FEBS Lett; 2019 Aug; 593(15):1879-1900. PubMed ID: 31199502 [TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor 23: state of the field and future directions. Bhattacharyya N; Chong WH; Gafni RI; Collins MT Trends Endocrinol Metab; 2012 Dec; 23(12):610-8. PubMed ID: 22921867 [TBL] [Abstract][Full Text] [Related]
13. Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model. Nakatani T; Ohnishi M; Razzaque MS FASEB J; 2009 Nov; 23(11):3702-11. PubMed ID: 19584304 [TBL] [Abstract][Full Text] [Related]
14. Klotho gene, phosphocalcic metabolism, and survival in dialysis. Torres PU; Prié D; Beck L; De Brauwere D; Leroy C; Friedlander G J Ren Nutr; 2009 Jan; 19(1):50-6. PubMed ID: 19121771 [TBL] [Abstract][Full Text] [Related]
16. Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23/Klotho system. Prié D; Friedlander G Clin J Am Soc Nephrol; 2010 Sep; 5(9):1717-22. PubMed ID: 20798257 [TBL] [Abstract][Full Text] [Related]